Results 171 to 180 of about 155,757 (387)

The Efficacy of Nasal Calcitonin on The Treatment of Osteoporosis in Male Patients with Ankylosing Spondylitis: A Preliminary Study - Original Investigation

Türk Osteoporoz Dergisi, 2007
Aim: Osteoporosis is a prominent feature of advanced ankylosing spondylitis and causes decrease in bone mineral density (BMD), disturbance of bone formation and resorption and incerase in incidence of vertebral fractures.
Pınar Borman, Hatice Bodur, Filiz Eser, Sezin Bingöl   +3 more
doaj  

Intracavernous Calcitonin-gene Related Peptide Plus Prostaglandin E 1. Possible Alternative to Penile Implants in Selected Patients. [PDF]

, 1994
Becker, Armin J., Djamilian, Mohamad H., Jonas, Udo, Kuczyk, M., Stief, Christian Georg, Thon, Walter F., Truss, Michael C.   +6 more
core   +1 more source

Joint Society Statement From the Society for Endocrinology (SfE), the British Thyroid Association (BTA) and the British Association of Endocrine and Thyroid Surgeons (BAETS) Regarding the Association of GLP‐1 Agonists and Thyroid Cancer

Clinical Endocrinology, EarlyView.
Emma Watts, Jonathan Wadsley, Neil Sharma, Kristien Boelaert, The UK Thyroid Cancer Study Group   +4 more
wiley   +1 more source

Insomnia severity in migraine: The role of headache frequency, aura status, and comorbidities—A cross‐sectional study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to investigate the association between migraine frequency and insomnia severity. Background Migraine and insomnia frequently co‐occur, yet the relationship between migraine characteristics and insomnia severity remains poorly understood.
Kuang‐Heng Lee, Chih‐Sung Liang, Po‐Kuan Yeh, Chia‐Kuang Tsai, Chia‐Lin Tsai, Yu‐Kai Lin, Guan‐Yu Lin, Ming‐Chen Tsai, Yi Liu, Yuan‐Zhen Ruan, Fu‐Chi Yang   +10 more
wiley   +1 more source

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary This study shows that galcanezumab is equally effective and well‐tolerated in patients aged 65 and older as in younger patients, with a higher proportion of excellent responders in older patients. Despite having more baseline headache days, older patients responded well to the treatment, with age being linked to better outcomes ...
Julia Peris‐Subiza, Víctor Obach, Daniel Guisado‐Alonso, Fernando Velasco Juanes, Rocío Álvarez Escudero, María Martín Bujanda, Sonsoles Aranceta, Aintzine Ruisánchez, Natalia Roncero, Ane Mínguez‐Olaondo, Amaya Echeverria, Alba López‐Bravo, Ángel Luis Guerrero‐Peral, David García‐Azorín, Elisa Cuadrado‐Godia, Galca‐Only Study Group, Neus Fabregat, Marta Ruibal, Izaro Kortazar Zubizarreta, Nuria Riesco, Lucia González‐Fernández, Paula Manera, Agustín Oterino Duran, Yésica González‐Osorio, Santiago Fernández‐Fernández, Juan Carlos García‐Moncó, Isabel Fernández‐Pérez, Joan Jiménez‐Balado   +27 more
wiley   +1 more source

Release of calcitonin gene‐related peptide from nerve terminals in rat skeletal muscle.

, 1991
Masahiko Sakaguchi, Yoko Inaishi, Y Kashihara, M. Kuno   +3 more
openalex   +2 more sources

ERT, HRT, Raloxifine, Calcitonin, or Bisphosphonates for Osteoporosis [PDF]

, 2003
Frederic R. Curtiss
openalex   +1 more source

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To evaluate the effect of erenumab treatment beyond monthly migraine days in patients with high‐frequency episodic migraine who did not respond to at least one previous migraine preventive treatment. Background Reduction in monthly migraine days has been the efficacy standard for migraine preventive treatments; however, it does not ...
Gabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, Sebastian Szklener, Cristina Tassorelli, Marcin Nastaj, Denise E. Chou, Ani C. Khodavirdi, Mahan Chehrenama, Yineng Zhu, Ajay K. Bhatia, David W. Dodick   +11 more
wiley   +1 more source

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Background The transient receptor potential melastatin 3 (TRPM3) ion channel has been implicated in sensory modulation and pain transmission and may contribute to migraine pathophysiology through calcitonin gene‐related peptide (CGRP) release in the trigeminovascular system. This study aimed to investigate TRPM3 activation and its role in CGRP
Philip V. Reducha, Lukas K. S. Nielsen, Mette N. Jensen, Jacob C. A. Edvinsson, Spyridoula Kazantzi, Sofia L. Wæver, Tanja Lylloff, Connar S. J. Westgate, Lars Edvinsson, Kristian A. Haanes   +9 more
wiley   +1 more source

Optimization of azepanone calcitonin gene-related peptide (CGRP) receptor antagonists: Development of novel spiropiperidines

, 2009
Christopher S. Burgey, Craig M. Potteiger, James Z. Deng, Scott D. Mosser, Christopher Salvatore, Sean Yu, Shane Roller, Stefanie A. Kane, Joseph P. Vacca, Theresa M. Williams   +9 more
openalex   +1 more source